Lightnews — Scholar-powered news

@onc-rg.bsky.social

We’ll be following how these subgroup analyses help define the role of PD-(L)1 x VEGF bispecifics in this dynamic and evolving space.
ONCrg SITC Conference Coverage details: onc-rg.com/conferences/...
#SITC2025 #NSCLC #ImmunoOncology #EGFR #LungCancerResearch #ClinicalTrials #ONCrg

SITC 2025 – Oncology Resource Group

onc-rg.com

October 30, 2025 at 7:42 PM Everybody can reply

Lumanity

@lumanity.bsky.social

We're looking forward to the Society for Immunotherapy of Cancer #SITC2025 and exploring cutting-edge research, initiatives, and advances in immuno-oncology! Email [email protected] to meet. buff.ly/9iCqJNh

#Immunotherapy #Oncology #ImmunoOncology #CancerResearch

October 28, 2025 at 4:00 PM Everybody can reply

ESMO - European Society for Medical Oncology

@myesmo.bsky.social

#ESMO25: Are personalised #CancerVaccines the next frontier or an elusive goal? Catherine Wu discusses the exciting potential of genomics-guided personalised vaccines and some of the related challenges.
#ESMODailyReporter 👉 https://ow.ly/aMxi50Xgn37

#ImmunoOncology

October 23, 2025 at 10:25 AM Everybody can reply

3 reposts 3 likes

3 3

ESMO - European Society for Medical Oncology

@myesmo.bsky.social

#ESMO25: Immune and angiogenic proteins were identified as potential #biomarkers for worse outcomes with atezolizumab plus chemotherapy followed by niraparib in the ANITA #ClinicalTrial in recurrent #OvarianCancer.
#ESMODailyReporter ➡️ https://ow.ly/S46G50XeOXt
#ImmunoOncology

October 22, 2025 at 2:15 PM Everybody can reply

2 likes

1 2

Lumanity

@lumanity.bsky.social

Join us November 19 for a live webinar with leading scientists, biotech innovators, and investment strategists, to explore questions and strategies surrounding IO beyond 2026. Register: buff.ly/xP45NMu #ImmunoOncology #CancerProgress #Biotech #Pharma #DrugDevelopment

October 22, 2025 at 7:00 AM Everybody can reply

MedChemExpress

@medchemexpress.bsky.social

📎 feeds.issuerdirect.com/news-release...

💡Research-use pembrolizumab from MedChemExpress: medchemexpress.com/Lambrolizuma...

#ESMO2025 #ESMO25 #mRNA #Inhibitors #CancerTherapy #ImmunoOncology #CheckpointInhibitors

October 22, 2025 at 6:20 AM Everybody can reply

Oncology Resource Group (ONCrg)

@onc-rg.bsky.social

Last year at SITC, discussants highlighted two areas they saw as the future of immunotherapy: vaccines and cell therapies. Fast forward to 2025, and the agenda reflects that very prediction. The ONCrg team will be onsite covering the latest data.
#ImmunoOncology #MarketInsights #ClinicalResearch

October 21, 2025 at 9:45 PM Everybody can reply

ESMO - European Society for Medical Oncology

@myesmo.bsky.social

#ESMO25: Studies investigated different approaches to restore sensitivity in anti-PD-(L)1 relapsed/refractory solid tumours: GDF-15 inhibition, mRNA-based therapy and targeting VISTA. Read more in the #ESMODailyReporter 📌 https://ow.ly/H8S950XeQQj

#ImmunoOncology

October 21, 2025 at 10:00 AM Everybody can reply

2 likes

2

ESMO - European Society for Medical Oncology

@myesmo.bsky.social

Data presented at #ESMO25 in extensive-stage #SCLC suggest new #ImmunoOncology combinations for first-line therapy (with tarlatamab) and maintenance treatment (with ceralasertib) may be on the horizon.
Read more in the #ESMODailyReporter 👉 https://ow.ly/Pwlf50XeswA

#LungCancer

October 18, 2025 at 7:10 AM Everybody can reply

1 likes

1

Fios Genomics

@fiosgenomics.bsky.social

In this blog we demonstrate how #bioinformatics analysis is beneficial for the assessment of novel immuno-oncology therapies. Read it now!
https://www.fiosgenomics.com/using-bioinformatics-to-assess-novel-immuno-oncology-therapies/
#oncology #immunooncology

October 15, 2025 at 1:30 PM Everybody can reply

Stephanie Flores

@icis-stephanie.bsky.social

Clinical trials are getting INTERESTING 👀
Memory-like NK cells for ovarian cancer? IL-18 CAR-T for leukemia? The translational game is strong right now.
Full list: signals.cytokinesociety.org/clinical-tri...
#ClinicalTrials #TranslationalResearch #ImmunoOncology #ScienceToPatients

Clinical Trials - Biweekly newsletter of the International Cytokine & Interferon Society

Updated monthly, these posts spotlight trials of interest to cytokine researchers from ClinicalTrials.gov. The website is maintained by the National Library of Medicine,

signals.cytokinesociety.org

October 13, 2025 at 7:04 PM Everybody can reply

Cancer Control

@cancer-control.bsky.social

Comprehensive review published in Cancer Control synthesizing #ClinicalTrials data on #OncolyticViruses (OVs) spanning 2013-2024. Provides an in-depth examination of OVs, highlighting their advancement from investigational modalities to clinical implementation. #ImmunoOncology #Virotherapy

October 7, 2025 at 12:03 PM Everybody can reply

1 likes

1

OncoDaily

@oncodaily.bsky.social

10 Must-Read Posts in Immuno-Oncology This Week

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IO #ImmunoOncology

10 Must-Read Posts in Immuno-Oncology This Week - OncoDaily

10 Must-Read Posts in Immuno-Oncology This Week / Annette Künkele, cancer, cancer immunotherapy, CRISPR, Dirk H. Busch, Elvira D'Ippolito, ICI, Karl Petri,

oncodaily.com

September 29, 2025 at 9:29 PM Everybody can reply

2 likes

2

Nanolive

@nanolive-sa.bsky.social

📢 New Newsletter is Out!

Welcome to the September edition of the AI for Live Cell Insights Newsletter. 👉 Read the full newsletter here: bit.ly/4865oeM

#AI #DrugDiscovery #CellBiology #ImmunoOncology #Nanolive

September 29, 2025 at 8:53 AM Everybody can reply

Fios Genomics

@fiosgenomics.bsky.social

In this blog we demonstrate how #bioinformatics analysis is beneficial for the assessment of novel immuno-oncology therapies. Read it now!
https://www.fiosgenomics.com/using-bioinformatics-to-assess-novel-immuno-oncology-therapies/
#oncology #immunooncology

September 19, 2025 at 10:55 AM Everybody can reply

Proceedings Series MDPI

@proceedingsmdpi.bsky.social

Breaking News in Cancer Immunotherapy!

Highlights from FIT Cancer 11 (Madrid, 2025) — Spain’s premier #ImmunoOncology meeting organized by GETICA_Spain
www.mdpi.com/2673-9992/36...

Dive into the abstracts shaping the future of #CancerImmunotherapy

#CellTherapy #Biomarkers

September 15, 2025 at 2:46 PM Everybody can reply

OncoDaily

@oncodaily.bsky.social

10 Must-Read Posts in Immuno-Oncology This Week

@patrickhwumd.bsky.social

oncodaily.com/societies/im...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IO #ImmunoOncology

10 Must-Read Posts in Immuno-Oncology This Week - OncoDaily

This week’s expert highlights in immuno-oncology spotlight trial updates, novel combinations, and leading voices shaping the future of cancer immunotherapy.

oncodaily.com

September 14, 2025 at 1:25 PM Everybody can reply

1 reposts 4 likes

1 4

Eternal HellCat War

@eternalcatwar.bsky.social

I used to work at a company that used CRISPR for Immunooncology and I got sooooooo much mileage out of this pic

September 11, 2025 at 1:07 AM Everybody can reply

9 likes

1 9

OncoDaily

@oncodaily.bsky.social

10 Must-Read Posts in Immuno-Oncology This Week

@biagioricciutimd.bsky.social @hhorinouchi.bsky.social @drewmoghanaki.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IO #ImmunoOncology

10 Must-Read Posts in Immuno-Oncology This Week - OncoDaily

10 Must-Read Posts in Immuno-Oncology This Week / Alfonso Duenas Gonzalez, Antonio Nuccio, Biagio Ricciuti, cancer, CAR-T therapy advancements, Christina

oncodaily.com

September 7, 2025 at 4:37 PM Everybody can reply

1 reposts 4 likes

1 4

Molecular Oncology

@moloncology.bsky.social

🔍 We are looking for papers!

🤝 In conjunction with the @EACRnews conference on #ImmunoOncology we have an active call for papers!

📩 Submit your latest research in the field of #CancerImmunology #ImmunoOnc

👉 Find out more details buff.ly/ZDb3rO0

September 2, 2025 at 8:58 AM Everybody can reply

OncoDaily

@oncodaily.bsky.social

10 Must-Read Posts in Immuno-Oncology This Week

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IO #ImmunoOncology

10 Must-Read Posts in Immuno-Oncology This Week - OncoDaily

10 Must-Read Posts in Immuno-Oncology This Week / Anthony K Park, Breast Cancer, cancer, cancer immunotherapy, Christopher Heery, colorectal cancer, Eric

oncodaily.com

August 31, 2025 at 5:57 PM Everybody can reply

2 likes

2

Nanolive

@nanolive-sa.bsky.social

How fast do T cells engage? How sustained is their killing? Traditional assays can’t answer.

Nanolive’s LIVE T Cell Assay reveals T cell–mediated killing in real time: label-free & dynamic.

🔗 bit.ly/3VbNUWv

#TCells #ImmunoOncology #Cytotoxicity